Index Ventures Raises $198M for First Dedicated Life Sciences Fund, Teams with GSK and J&J

The €150 million ($198 million) life sciences fund counts as anchor LPs GlaxoSmithKline and the venture capital affiliate of the Janssen pharmaceutical companies of Johnson & Johnson.